Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), a biopharmaceutical company with a market capitalization of $2.68 billion ...
Myocyte death and formation of new myocytes by the CSCs are the two processes that enable this organ to maintain a proper and uninterrupted cardiac output from birth to adulthood and into old age.
More information: Yuhua Wei et al, Follistatin From hiPSC-Cardiomyocytes Promotes Myocyte Proliferation in Pigs With Postinfarction LV Remodeling, Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback